CTS stock jumped 7.1% to US$64.72 on Tuesday as investors rushed to price in a punchy second quarter. The headline is clear for you as a shareholder: margins hit fresh highs and adjusted earnings beat the steady revenue base.

Behind that price pop, CTS delivered record adjusted gross margin and record adjusted diluted earnings per share, helped by foreign exchange and a customer reimbursement. The move leaves the stock trading above a recently estimated discounted cash flow value, which puts the focus squarely on how durable these margin gains and earnings levels look over the next few years.

Is CTS now pricing in too much future profit, or is the market still underrating these record margins at US$64.72? Compare the current share price against detailed cash flow assumptions in our valuation analysis for CTS

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs. Q2 2025): US$144.78 million vs. US$135.31 million (up 7.0%)
• Net Income (Q2 2026 vs. Q2 2025, excl. extra items): US$19.16 million vs. US$18.53 million (up 3.4%)
• Basic EPS (Q2 2026 vs. Q2 2025): US$0.67 vs. US$0.62 (up 7.6%)
• Trailing 12 Month Net Income (Q2 2026 TTM vs. Q2 2025 TTM, excl. extra items): US$69.79 million vs. US$64.18 million (up 8.7%)

Prefer clean charts instead of another wall of earnings tables and footnotes? Get a full visual view of CTS, with a focus on its valuation picture, in the company report for CTS.

CTS bull case: mix shift finally showing up

The upbeat story around CTS is that the shift toward higher margin, diversified end markets will support multi year revenue growth and steadier margin expansion. Q2 puts some real proof points on that claim. Diversified end markets now account for 59% of sales, up from 55% a year ago, with revenue in these segments up 15% year on year and book to bill at 1.17. Medical and industrial both delivered double digit growth and healthy booking ratios, which backs the idea of a stronger, higher value portfolio. Record adjusted gross margin of 41.5% and adjusted EBITDA margin of 25.4% show the mix shift and operational discipline starting to flow through. Guidance for 2026 revenue of US$565 to US$585m and adjusted EPS of US$2.55 to US$2.70 signals management confidence that this margin structure is not just a one quarter event.

CTS bear case: quality of earnings and cyclic risk

The cautious view is that CTS carries elevated expectations while still exposed to transportation and episodic government or medical demand. Q2 does not eliminate those worries. Transportation revenue fell 2% year on year and sequentially, and aerospace and defense revenue fell 15% year on year, with management pointing to funding timing rather than underlying strength. Bears who worry about earnings quality also get ammunition. Record adjusted EPS of US$0.74 included about US$0.07 from foreign exchange and a customer reimbursement, which inflates the run rate. Management highlighted tariff, precious metal and input cost risks that could pressure margins, and called out variability in government funded programs and medical bookings. With diversified growth offset by softer transportation and aerospace and defense, the quarter partly answers the bear case on mix, but leaves questions on how much of today’s margin is repeatable.

Compare how CTS management discusses margin durability with how Wall Street is updating its models. See the consensus price target analysis for CTS to check whether analyst targets are keeping pace with the post earnings share price move.

Stay Ahead With CTS And Simply Wall St

If CTS looks interesting after its record margins and earnings beat, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch how the story develops from here. Once you are invested, use the Portfolio Command Center to cut through noise and focus on key developments that matter for your holdings. For a longer term view, tap into crowd insights and discussion through the Community to see how other investors are reacting to new information. By spotting potential catalysts and risks early, you give yourself a better chance of staying a step ahead of the market.

Seeking Alternatives Beyond CTS Stock

Fresh ideas do not stay quiet for long. Spot potential breakout stories before the crowd, while the data still matters and under the radar for now. Get in early.

• Chase future income streams with a curated pool of companies built around dependable payouts using the 8 dividend fortresses.
• Track where real momentum could meet solid finances by scanning a tight set of resilient businesses through the 84 resilient stocks with low risk scores.
• Hunt for fast moving growth potential in curated early stage opportunities using the 20 elite penny stocks with strong financials.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.